Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Robo Global Robotics & Automation ETF (ROBO) vs Sana Biotechnology Inc (SANA) Price & Performance

Global X Robo Global Robotics & Automation ETFTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Global X Robo Global Robotics & Automation ETF vs Sana Biotechnology Inc — how do they compare? Global X Robo Global Robotics & Automation ETF trades at $79.51, while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Global X Robo Global Robotics & Automation ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

ROBOSANA
Sector
Sector/ThematicHealth
52-Week High
$90.34$5.92
52-Week Low
$61.34$2.68
Market Cap
$873.84M
Enterprise Value
$848.03M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Robo Global Robotics & Automation ETF

ROBO trades at $77.31, down 0.74% today, with a bearish technical signal from moving averages but bullish oscillators. Recent news highlights robotics as the next AI investment wave, with ROBO positioned in physical automation. Financial ratios are unavailable, but thematic ETF inflows suggest growing investor interest in robotics and AI infrastructure.

Outlook is cautiously optimistic due to AI-driven demand for robotics, though cyclical exposure and valuation concerns pose risks. The ETF's diversification across machinery and electronics offers growth potential, but investors should monitor earnings momentum and sector rotation trends for sustained upside.

Sana Biotechnology Inc

SANA Biotechnology trades at $3.14, down 0.32% with a bearish technical signal. The company shows negative profitability metrics with ROE at -147.41% and net income of -$244.17M for 2025, though cash burn is projected to improve significantly in 2026. Recent positive developments include NEJM publication of groundbreaking diabetes data and multiple conference presentations highlighting clinical progress.

While analyst sentiment remains strongly bullish (82% buy ratings), the stock faces fundamental challenges with significant losses and high P/B ratio of 7.33. Investment opportunity lies in clinical pipeline advancements, but risks include ongoing cash burn and execution challenges in bringing therapies to market.

Returns comparison

Trailing returns across standard periods

About Global X Robo Global Robotics & Automation ETF

ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.

Read more on ROBO

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA